Cite

HARVARD Citation

    Nishikawa, H. et al. (2017). Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis. Journal of cachexia, sarcopenia and muscle. 8 (6), pp. 915-925. [Online]. 
  
Back to record